0 avis
Melatonin MT 1 and MT 2 receptor ERK signaling is differentially dependent on G i/o and G q/11 proteins
Archive ouverte
International audience. Abstract G protein‐coupled receptors (GPCRs) transmit extracellular signals into cells by activating G protein‐ and β‐arrestin‐dependent pathways. Extracellular signal‐regulated kinases (ERKs) play a central role in integrating these different linear inputs coming from a variety of GPCRs to regulate cellular functions. Here, we investigated human melatonin MT 1 and MT 2 receptors signaling through the ERK1/2 cascade by employing different biochemical techniques together with pharmacological inhibitors and siRNA molecules. We show that ERK1/2 activation by both receptors is exclusively G protein‐dependent, without any participation of β‐arrestin1/2 in HEK293 cells. ERK1/2 activation by MT 1 is only mediated though G i/o proteins, while MT 2 is dependent on the cooperative activation of G i/o and G q/11 proteins. In the absence of G q/11 proteins, however, MT 2 ‐induced ERK1/2 activation switches to a β‐arrestin1/2‐dependent mode. The signaling cascade downstream of G proteins is the same for both receptors and involves activation of the PI3K/PKCζ/c‐Raf/MEK/ERK cascade. The differential G protein dependency of MT 1 ‐ and MT 2 ‐mediated ERK activation was confirmed at the level of EGR1 and FOS gene expression, two ERK1/2 target genes. G i/o /G q/11 cooperativity was also observed in Neuroscreen‐1 cells expressing endogenous MT 2 , whereas in the mouse retina, where MT 2 is engaged into MT 1 /MT 2 heterodimers, ERK1/2 signaling is exclusively G i/o ‐dependent. Collectively, our data reveal differential signaling modes of MT 1 and MT 2 in terms of ERK1/2 activation, with an unexpected G i/o /G q/11 cooperativity exclusively for MT 2 . The plasticity of ERK activation by MT 2 is highlighted by the switch to a β‐arrestin1/2‐dependent mode in the absence of G q/11 proteins and by the switch to a G i/o mode when engaged into MT 1 /MT 2 heterodimers, revealing a new mechanism underlying tissue‐specific responses to melatonin.